AGN 2.36% 72.3¢ argenica therapeutics limited

Ann: Safety Review Committee Approves Third Cohort Commencement, page-3

  1. 9,854 Posts.
    lightbulb Created with Sketch. 979
    Beautiful.
    Phase 1 progressing well.
    Half way through the cohorts.

    I wonder if they are still monitoring cohort 1.
 
watchlist Created with Sketch. Add AGN (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.